Literature DB >> 11137756

Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation.

T Sugiura1, N Yoshinaga, K Waku.   

Abstract

Rat brain, frozen in liquid nitrogen immediately after decapitation, contains a substantial amount of 2-arachidonoylglycerol (0.34 nmol/g tissue), an endogenous cannabinoid receptor ligand. The level of 2-arachidonoylglycerol in the brain was rapidly augmented after decapitation, the peak being noted 30 s after decapitation (1.54 nmol/g tissue). Noticeably, there are two phases during the increase in the levels of 2-arachidonoylglycerol: a rapid transient increase and a subsequent gradual sustained increase, suggesting that at least two separate mechanisms are involved in the generation of 2-arachidonoylglycerol in the decapitated brain. Gradual sustained formation was also observed for other monoacylglycerols, (e.g. 2-palmitoylglycerol plus 2-oleoylglycerol and 2-cis-vaccenoylglycerol). Thus, it is important to minimize post-mortem changes to estimate the exact tissue levels of 2-arachidonoylglycerol as well as other monoacylglycerols in the brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137756     DOI: 10.1016/s0304-3940(00)01691-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  The endocannabinoid system: a general view and latest additions.

Authors:  Luciano De Petrocellis; Maria Grazia Cascio; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

2.  The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors.

Authors:  A Chicca; J Marazzi; J Gertsch
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

3.  An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction.

Authors:  C R Hutch; C J Hillard; C Jia; C C Hegg
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 4.  Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.

Authors:  Matthew W Buczynski; Loren H Parsons
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

5.  Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain.

Authors:  M Palkovits; J Harvey-White; J Liu; Z S Kovacs; M Bobest; G Lovas; A G Bagó; G Kunos
Journal:  Neuroscience       Date:  2008-02-05       Impact factor: 3.590

Review 6.  Role of cannabinoids and endocannabinoids in cerebral ischemia.

Authors:  Cecilia J Hillard
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

7.  Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters.

Authors:  JodiAnne T Wood; John S Williams; Lakshmipathi Pandarinathan; Amber Courville; Melissa R Keplinger; David R Janero; Paul Vouros; Alexandros Makriyannis; Carol J Lammi-Keefe
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

8.  Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation.

Authors:  Stephen A Brose; Svetlana A Golovko; Mikhail Y Golovko
Journal:  Lipids       Date:  2016-03-28       Impact factor: 1.880

Review 9.  Analysis of endocannabinoids, their congeners and COX-2 metabolites.

Authors:  Philip J Kingsley; Lawrence J Marnett
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-05-21       Impact factor: 3.205

10.  Comparative effects of parathion and chlorpyrifos on extracellular endocannabinoid levels in rat hippocampus: influence on cholinergic toxicity.

Authors:  Jing Liu; Loren Parsons; Carey Pope
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-07       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.